← Open Payments lookup

MICHAEL STEWART: Open Payments

NPI 1154604205 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,429 in 105 payments from 14 companies in 2025. Trend: 2023 $1,287 · 2024 $952 · 2025 $3,429

Food & beverage: $3,429
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$707
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$539
Alkermes, Inc.13$408
Indivior Inc.12$330
E.R. Squibb & Sons, L.L.C.11$281
Janssen Pharmaceuticals, Inc8$264
Neurocrine BioSciences, Inc.9$261
Lundbeck LLC5$190
Teva Pharmaceuticals USA, Inc.4$159
Braeburn Inc.1$125

Products named: REXULTI, CAPLYTA, SUBLOCADE, COBENFY, ARISTADA, INVEGA SUSTENNA, INGREZZA, ABILIFY MAINTENA.

Industry payments across MI — which companies pay providers there.